Delay-and-pay: prolonging pharmaceutical patent protection without paying the ‘price’

<p>This thesis argues that actors use the patent system as part of a ‘delay-and-pay’ strategy to preserve drug prices for as long as possible by delaying generic/biosimilar market entry – and that they have a significant incentive to do so. This strategy is based on the notion that it is signi...